loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 202514 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 TAFLUPROST (1)

filter

01 THEA PHARMA (1)

filter

01 SOLUTION/DROPS;OPHTHALMIC (1)

filter

01 0.0015% (1)

filter

01 USA (1)

URL Supplier Web Content
SOLUTION/DROPS;OPHTHAL...
0.0015%
ZIOPTAN
USA
202514
2012-02-10
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 202514

Looking for CTD TGA MCC DOSSIER APPLICATION 202514 1

19

Thea Pharma, based in U.S.A, is a pharmaceutical company.

One of their notable products is TAFLUPROST, with a corresponding application number 202514 and regulatory information .

proudly manufactured in the

approval since 2012-02-10

Thea Pharma's ZIOPTAN SOLUTION/DROPS;OPHTHALMIC, medication with 0.0015% of TAFLUPROST.

Post Enquiry
POST ENQUIRY